The Role of Intrinsic Pathway in Apoptosis Activation and Progression in Peyronie's Disease

Peyronie's disease (PD) is characterized with formation of fibrous plaques which result in penile deformity, pain, and erectile dysfunction. The aim of this study was to investigate the activation of the intrinsic apoptotic pathway in plaques from PD patients. Tunica albuginea from either PD or control patients was assessed for the expression of bax, bcl-2 and caspases 9 and 3 using immunohistochemistry and by measurement of apoptotic cells using TUNEL assay. Bax overexpression was observed in metaplastic bone tissue, in fibroblasts, and in myofibroblast of plaques from PD patients. Little or no bcl-2 immunostaining was detected in samples from either patients or controls. Caspase 3 immunostaining was very strong in fibrous tissue, in metaplasic bone osteocytes, and in primary ossification center osteoblasts. Moderate caspase 9 immunostaining was seen in fibrous cells plaques and in osteocytes and osteoblasts of primary ossification centers from PD patients. Control samples were negative for caspase 9 immunostaining. In PD patients the TUNEL immunoassay showed intense immunostaining of fibroblasts and myofibroblasts, the absence of apoptotic cells in metaplasic bone tissue and on the border between fibrous and metaplastic bone tissue. Apoptosis occurs in stabilized PD plaques and is partly induced by the intrinsic pathway.

[1]  George Bou-Gharios,et al.  Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model. , 2002, Nitric oxide : biology and chemistry.

[2]  E. Rowinsky.  Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  M. Ferrini,et al.  Aging-related expression of inducible nitric oxide synthase and markers of tissue damage in the rat penis , 2002, International Journal of Impotence Research.

[4]  J. Sznajder,et al.  Gelatinases A and B are up-regulated in rat lungs by subacute hyperoxia: pathogenetic implications. , 1998, The American journal of pathology.

[5]  G. Musumeci,et al.  Apoptosis in temporomandibular joint disc with internal derangement involves mitochondrial-dependent pathways. An in vivo study , 2013, Acta odontologica Scandinavica.

[6]  M. Gelbard.  Myofibroblasts and mechanotransduction: do forces in the tunica albuginea contribute to Peyronie's disease? , 2008, The journal of sexual medicine.

[7]  J. Rajfer,et al.  Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy , 2010, Nature Reviews Urology.

[8]  Z. Oltvai,et al.  BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax , 1994, Nature.

[9]  G. Musumeci,et al.  Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its death receptor (DR5) in Peyronie's disease. A biomolecular study of apoptosis activation. , 2011, The journal of sexual medicine.

[10]  A. G. Hermans.  [Peyronies disease]. , 1952, Nederlands tijdschrift voor geneeskunde.

[11]  C. Davis.  The microscopic pathology of Peyronie's disease. , 1997, The Journal of urology.

[12]  S. Sansalone,et al.  Peyronie's Reconstruction for Maximum Length and Girth Gain: Geometrical Principles , 2008, Advances in urology.

[13]  W. Hellstrom,et al.  Intralesional injection therapy for Peyronie's disease. , 2009, The journal of sexual medicine.

[14]  A. Bella,et al.  Protein biomarker analysis of primary Peyronie's disease cells. , 2010, The journal of sexual medicine.

[15]  S. Minhas,et al.  The management of Peyronie's disease , 2004, BJU international.

[16]  T. Lue,et al.  Physiology of penile erection and pathophysiology of erectile dysfunction. , 2005, The Urologic clinics of North America.

[17]  J. Rajfer,et al.  Mechanisms of Disease: new insights into the cellular and molecular pathology of Peyronie's disease , 2005, Nature Clinical Practice Urology.

[18]  S. Korsmeyer.  Bcl-2 initiates a new category of oncogenes: regulators of cell death. , 1992, Blood.

[19]  K. Somers,et al.  Fibrin deposition in Peyronie's disease plaque. , 1997, The Journal of urology.

[20]  J. Jarow,et al.  Penile trauma: an etiologic factor in Peyronie's disease and erectile dysfunction. , 1997, The Journal of urology.

[21]  G. Musumeci,et al.  Possible role of apoptosis in the pathogenesis and clinical evolution of radicular cyst: an immunohistochemical study. , 2013, International endodontic journal.

[22]  G. Jordan,et al.  Surgery of the Penis and Urethra , 2012 .

[23]  S. Thorgeirsson,et al.  Induction of p53 and Bax during TGF-beta 1 initiated apoptosis in rat liver epithelial cells. , 1998, Biochemical and biophysical research communications.

[24]  G. Musumeci,et al.  Cryopreserved penile tunica albuginea for allotransplantation: a morphological and ultrastructural investigation. , 2012, The journal of sexual medicine.

[25]  C. Loreto,et al.  TRAIL, DR5 and caspase 3-dependent apoptosis in vessels of diseased human temporomandibular joint disc. An immunohistochemical study , 2010, European journal of histochemistry : EJH.

[26]  N. Longo,et al.  A new mouse model of Peyronie's disease: an increased expression of hypoxia-inducible factor-1 target genes during the development of penile changes. , 2008, The international journal of biochemistry & cell biology.

[27]  S. Mardini,et al.  Penile reconstruction. , 2011, Seminars in plastic surgery.

[28]  W. Hellstrom,et al.  Peyronie's disease: etiology, medical, and surgical therapy. , 2000, Journal of andrology.

[29]  R. M. Nesbit.  CONGENITAL CURVATURE OF THE PHALLUS: REPORT OF THREE CASES WITH DESCRIPTION OF CORRECTIVE OPERATION. , 1965, Transactions of the American Association of Genito-Urinary Surgeons.

[30]  A. Melman,et al.  The genetics and immunology of Peyronie's disease , 2000, International Journal of Impotence Research.

[31]  M. Ferrini,et al.  Antifibrotic role of inducible nitric oxide synthase. , 2002, Nitric oxide : biology and chemistry.

[32]  M. Ferrini,et al.  Fibrin as an inducer of fibrosis in the tunica albuginea of the rat: a new animal model of Peyronie's disease , 2003, BJU international.

[33]  S. Korsmeyer,et al.  Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.

[34]  Hyunseung Lee,et al.  A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie's plaques. , 2013, International journal of oncology.

[35]  W. Hellstrom,et al.  A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. , 2000, The Journal of urology.

[36]  H. Ehrlich.  Scar contracture: cellular and connective tissue aspects in Peyronie's disease. , 1997, The Journal of urology.

[37]  David L. Vaux,et al.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.

[38]  T. Lue,et al.  Peyronie's disease. , 1998, International journal of impotence research.

[39]  C. Loreto,et al.  Apoptosis in displaced temporomandibular joint disc with and without reduction: an immunohistochemical study. , 2011, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[40]  S. Fesik,et al.  Insights into Programmed Cell Death through Structural Biology , 2000, Cell.

[41]  G. Musumeci,et al.  Post-Traumatic Caspase-3 Expression in the Adjacent Areas of Growth Plate Injury Site: A Morphological Study , 2013, International journal of molecular sciences.

[42]  M. Ferrini,et al.  Gene expression in Peyronie's disease , 2002, International Journal of Impotence Research.

[43]  U. Ozbek,et al.  Comparison of apoptotic gene expression profiles between Peyronie's disease plaque and tunica albuginea. , 2012, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[44]  G. Lin,et al.  Pentoxifylline attenuates transforming growth factor-β1-stimulated collagen deposition and elastogenesis in human tunica albuginea-derived fibroblasts part 1: impact on extracellular matrix. , 2010, The journal of sexual medicine.

[45]  G. Jordan,et al.  Proposal: trauma as the cause of the Peyronie's lesion. , 1996, The Journal of urology.

[46]  B. Huppertz,et al.  The apoptosis cascade — morphological and immunohistochemical methods for its visualization , 1999, Anatomy and Embryology.

[47]  H. Puthalakath,et al.  Bcl‐2 family proteins: The sentinels of the mitochondrial apoptosis pathway , 2008, IUBMB life.